Investigation of an aerosol challenge model as alternative to the intracerebral mouse protection test for potency assay of whole cell pertussis vaccines

Biologicals

Volumn 28, Issue 4, 2000, Pages 241-246

  Canthaboo, Catpagavalli ^a   Xing, Dorothy ^a   Douglas, Alexandra ^a   Corbel, Michael ^a  

^a NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PERTUSSIS VACCINE;

AEROSOL; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BORDETELLA PERTUSSIS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DOSE RESPONSE; DRUG POTENCY; DRUG SCREENING; FEMALE; INFECTION PREVENTION; INTERMETHOD COMPARISON; MOUSE; NONHUMAN; OBSERVER VARIATION; PERTUSSIS; PRIORITY JOURNAL; REPRODUCIBILITY; VACCINATION;

ANIMALIA; BORDETELLA PERTUSSIS;

EID: 0034461583     PISSN: 10451056     EISSN: None     Source Type: Journal    
DOI: 10.1006/biol.2000.0263     Document Type: Article

References (15)

1. Mouse protection tests in the study of pertussis vaccines: A comparative series using the intracerebral route of challenge
2. Vaccination against whooping cough. The final report
3. Collaborative study on test systems to assess toxicity of whole cell pertussis vaccine
4. Development of pertussis serological potency test
5. Cell-mediated immunity to Bordetella pertussis: Role of Th1 cells in bacterial clearance in a murine respiratory infection model
6. Cell-mediated immune responses to antigens of Bordetella pertussis and protection against pertussis in school children
7. Placebo-controlled trial of two acellular pertussis vaccines in Sweden protective efficacy and adverse events
8. Comparative efficacy of acellular pertussis vaccines: An analysis of recent trials
9. Pertussis: Current concepts of pathogenesis and prevention
10. Aerosol infection of mice with Bordetella pertussis
11. Proliferative responses and gamma interferon and tumor necrosis factor production by lymphocytes isolated from tracheobroncheal lymph nodes and spleens of mice aerosol infected with Bordetella pertussis
12. A murine model in which protection correlates with pertussis vaccine efficacy in children reveals complementary roles for humoral and cell-mediated immunity in protection against Bordetella pertussis
13. An aerosol challenge model of Bordetella pertussis infection as a potential bioassay for acellular pertussis vaccines
14. Intranasal murine model of Bordetella pertussis infection. I. Prediction of protection in human infants by acellular vaccines
15. A simple chemically defined medium for the production of phase I Bordetella pertussis